Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Steatotic liver disease and cancer: from pathogenesis to therapeutic targets. | eGastroenterology | 2025 | 41098801 | PubTator, text mining | PubMed |
| The impact of the PNPLA3 rs738406 C>G polymorphism on hepatocellular carcinoma risk in Brazilian patients with chronic hepatitis C and advanced fibrosis. | Clinics (Sao Paulo) | 2025 | 41092564 | PubTator, text mining | PubMed |
| Clinical Predictors of Progression From Metabolic Dysfunction-Associated Steatotic Liver Disease to Cirrhosis: A Narrative Review. | Cureus | 2025 | 41054643 | PubTator, text mining | PubMed |
| Identification of key lipid metabolism-related genes in kidney fibrosis: implications for chronic kidney disease management. | Front Physiol | 2025 | 41049486 | PubTator, text mining | PubMed |
| PNPLA3-I148M is a neomorph that interferes with two primary hepatic triglyceride clearance pathways. | Cell Rep | 2025 | 41046517 | PubTator, text mining | PubMed |
| Cross-ancestry discovery of genetic risk variants for lean metabolic dysfunction-associated steatotic liver disease. | Cell Biosci | 2025 | 41039588 | PubTator, text mining | PubMed |
| Genomic medicine in hepatology: mechanisms and liver treatment strategies. | Mol Med | 2025 | 41023586 | PubTator, text mining | PubMed |
| Hot and Cold HCC: Uncoupling Viral Oncogenesis and Therapy. | Viruses | 2025 | 41012682 | PubTator, text mining | PubMed |
| Genetic drivers of liver cirrhosis: The role of SERPINA1 and PNPLA3 variants in disease onset and progression. | PLoS One | 2025 | 41004464 | PubTator, text mining | PubMed |
| Metabolic Signatures in Lean MASLD: Current Insights and Future Directions. | Metabolites | 2025 | 41002967 | PubTator, text mining | PubMed |
| Metabolic and genetic mechanisms of metabolic dysfunction-associated steatotic liver disease: an integrative perspective from molecular pathways to clinical challenges. | Front Endocrinol (Lausanne) | 2025 | 41001677 | PubTator, text mining | PubMed |
| Germline Variants Influence Chronic Liver Disease Progression through Distinct Pathways. | medRxiv | 2025 | 41001506 | PubTator, text mining | PubMed |
| Global burden of chronic liver disease due to NAFLD from 2012 to 2021: A trend, decomposition, and health inequality analysis. | Diabetol Metab Syndr | 2025 | 40999480 | PubTator, text mining | PubMed |
| Genetic risk score correlates with immune profile and risk of HCC and cirrhosis development in Hispanics with MASLD. | JHEP Rep | 2025 | 40995436 | PubTator, text mining | PubMed |
| Integrated Genomic Analysis Reveals the Synergistic Role of PNPLA3 and ABCC8 Variants in Diabetic MASLD in Pakistan. | Med Sci (Basel) | 2025 | 40981175 | PubTator, text mining | PubMed |
| PNPLA3 polymorphism worsens chemotherapy associated liver injury and affects overall survival in colorectal cancer patients with liver metastasis undergoing hepatic resection. | EBioMedicine | 2025 | 40961507 | PubTator, text mining | PubMed |
| Screening for metabolic-associated fatty liver disease in type 2 diabetes patients using non-invasive scores and ultrasound: a cross-sectional study in Egypt. | BMC Gastroenterol | 2025 | 40954485 | PubTator, text mining | PubMed |
| Paradoxical association between steatotic liver disease and favorable hepatic outcomes in HCV patients with SVRs. | Hepatol Int | 2025 | 40946137 | PubTator, text mining | PubMed |
| Clinical and Genetic Predictors of Non-Alcoholic Steatotic Liver Disease and Fibrosis in Lean Individuals. | Liver Int | 2025 | 40944478 | PubTator, text mining | PubMed |
| Early Insights from Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Patients: An Observational Study on Polygenic Risk and Liver Biomarkers. | Int J Mol Sci | 2025 | 40943344 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=11